analysis | Second Opinion

Analysis

The FDA is cracking down on pharma advertising on TV

And it could impact digital health

Anjalee Khemlani

The FDA is cracking down on pharma advertising on TV

ChatGPT gave my patient the wrong prescription — here’s what it got right.

Plus, magnesium for hormones and 7k steps for longevity.Post

Christina Farr, +1

ChatGPT gave my patient the wrong prescription — here’s what it got right.

Round Up: A Tale of Two Health Systems, a Wave of Health-Tech News, and a Four Questions with Co-founder & CEO of Ambience

As Americans juggle cash-pay care and high-deductible insurance, companies like Aidoc, Datavant, and Prosper AI are testing whether tech can ease the pressure.

Christina Farr, +1

Round Up: A Tale of Two Health Systems, a Wave of Health-Tech News, and a Four Questions with Co-founder & CEO of Ambience

Let’s banish the term “worried well”

Plus, a review of Prenuvo’s enhanced screening

Let’s banish the term “worried well”

Roundup: The Return of Deals, the Rise of Wellness, and AI’s Coming Regulation

As startups chase hot markets like GLP-1s and testosterone, the Trump Administration continues to push on wellness - and not always with the evidence to back it up. Deals are finally ramping up (and why). Plus a “Four Questions with” interview with digital health OG Halle Tecco!

Christina Farr, +1

Roundup: The Return of Deals, the Rise of Wellness, and AI’s Coming Regulation

A top healthcare VC ponders whether there will be another value-based care home run

Why “Power Law” venture math is more challenging for value-based care, versus fee-for-service, and whether AI will make a difference

Christina Farr, +1

A top healthcare VC ponders whether there will be another value-based care home run

Employers, Payers, and Pharma Face a Post–Labor Day Reckoning

"Tectonic Shifts" are happening as inflation, drug pricing battles, and cash-pay healthcare are colliding to redefine the industry’s next era.

Employers, Payers, and Pharma Face a Post–Labor Day Reckoning

129 doctors, nurses and PAs told us about their longevity stack

Per our anonymous survey, this is what clinicians take & why

Christina Farr, +1

129 doctors, nurses and PAs told us about their longevity stack

A Definitive Guide: How to Get Paid for Treating Patients by Text

Reimbursement is patchy, but a big business will be created here as more patients gravitate to messaging

Christina Farr, +1

A Definitive Guide: How to Get Paid for Treating Patients by Text

Roundup: Testing Healthcare AI in Space, Increasing Statin Adoption, Epic's move into Scribing, etc

Plus Peloton's surprise profit, 4 Questions with the CSO of Solera Health and a hot-take on AI driven automation.

Christina Farr, +1

Roundup: Testing Healthcare AI in Space, Increasing Statin Adoption, Epic's move into Scribing, etc

How healthcare VC firms are thinking about longevity

7wire shared their thesis and market map with us that it created for its own LPs

How healthcare VC firms are thinking about longevity

Is your women's health business venture backable?

Part 1 in our founder's guide to financing your women's health startup

Leslie Schrock, +1

Is your women's health business venture backable?

23andMe should have raised less capital

My takeaway from today’s news that the company is filing for bankruptcy

23andMe should have raised less capital

What happened to the digital health unicorns of 2020 to 2022?

Guest author Halle Tecco’s breakdown of how the companies valued at more than $1b at the peak are faring — TLDR, the results surprised her!

What happened to the digital health unicorns of 2020 to 2022?

Why is longevity suddenly so hot?

Between Function Health, Lifeforce and Superpower, this space is on fire

Why is longevity suddenly so hot?

How are employers going to pay for cell and gene therapies?

Let’s get real about the alliance between U.S. health care and employment

How are employers going to pay for cell and gene therapies?